Form D · Biotechnology
Serometrix, LLC
Pittsford, NY · CIK 0001468560
Offering snapshot reported Jun 27, 2012 · SEC filing
- Reported sold
- $228K Offering amount: $1.23M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Mar 27, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 27, 2012 | Initial | $227,979 | No comparison | 9 | SEC filing |
| Jul 17, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-180355
Source: Form D, filed Jun 27, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle D. Monroe | Director, Executive |
| Michael M. Muehleman | Director, Executive |
| Michael M. Muehlemann | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
732 Pittsford Victor Road
Pittsford, NY, 14534
Pittsford, NY, 14534